OrbiMed
Biotechnology · Asset Management & Funds

OrbiMed portfolio

OrbiMed (Venture capital) is known to hold 197 companies, 75 of them startups. 48 of them are hiring now, with 364 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 19 venture rounds in 12 months, raising $1.6B. Most of them work in Health Care, Biotechnology, Artificial Intelligence.

Source: Alion Venture capital Nov 17, 2026
Investments
197
75 of them startups
Hiring now
48
364 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
19
$1.6B raised
Exits
57

Companies OrbiMed has invested in

STAR Therapeutics Venture round $200M · this month portfolio pageSep 25
Altis Labs Medical AI · Canada Series A $25M · 1 mo ago 6 roles portfolio pageSep 25
TytoCare Primary Care & Medical Centers · Israel Venture round $25M · 4 mo ago portfolio pageSep 25
Fore Biotherapeutics Series D $67.4M · 4 mo ago portfolio pageSep 25
Triveni Bio Biologics & Biosimilars Series C $65M · 5 mo ago portfolio pageSep 25
TruNativ India Series B $30M · 5 mo ago portfolio pageSep 25
Windward Bio Drug Discovery Venture round $165M · 6 mo ago lead portfolio page, round in the pressJan 13, 2025
Vivacta bio Series A · 6 mo ago portfolio pageSep 25
Terremoto Bio Drug Discovery · United States Venture round $40.7M · 7 mo ago portfolio pageSep 25
Sidewinder Therapeutics Biologics & Biosimilars Series B $137M · 7 mo ago portfolio pageSep 25
Stairmed China Venture round $500M · 7 mo ago 1 role portfolio pageSep 25
Congruence Venture round $39.5M · 7 mo ago portfolio pageSep 25
Sitala Venture round · 7 mo ago portfolio pageSep 25
Thrombolex United States Venture round $32.8M · 8 mo ago portfolio pageSep 25
QuantX Biosciences Series B $85M · 9 mo ago portfolio pageSep 25
biobeat Israel Series B $50M · 10 mo ago lead portfolio page, round in the pressDec 30, 2025
BlossomHill Therapeutics Oncology Therapeutics · United States Venture round $84.2M · 11 mo ago 2 roles portfolio pageSep 25
TandemAI Drug Discovery · China Series A $22M · 12 mo ago portfolio pageSep 25
Avenzo Therapeutics Oncology Therapeutics · United States Series B $60M · 13 mo ago 4 roles portfolio pageSep 25
Charm Therapeutics United Kingdom Series B $80M · 14 mo ago portfolio pageSep 25
Treeline Biosciences Drug Discovery · United States Venture round $200.1M · 14 mo ago 8 roles portfolio pageSep 25
Inspiremd Venture round $40.1M · 15 mo ago portfolio pageSep 25
vVARDIS Switzerland Venture round $50M · 16 mo ago portfolio pageSep 25
RenasantBio United States Venture round $30M · 17 mo ago portfolio pageSep 25
Alpheus Medical Oncology Therapeutics · United States Series B $60.5M · 18 mo ago portfolio pageSep 25
Ottimo Pharma Venture round · 20 mo ago portfolio pageSep 25
AER Therapeutics United States Venture round $5M · 21 mo ago portfolio pageSep 25
Verdiva Bio Cardiometabolic Therapeutics Series A $410M · 22 mo ago portfolio pageSep 25
Aerinmedical Venture round $32.5M · 23 mo ago portfolio pageSep 25
Alentis Therapeutics Biologics & Biosimilars Series D $181.4M · 2 yr ago lead portfolio page, round in the pressNov 12, 2024
Iambic Therapeutics Drug Discovery AI · United States Convertible Note $75k · 2 yr ago portfolio pageSep 25
Alumis Immunology & Inflammation Therapeutics · United States Venture round $40M · 2 yr ago 4 roles portfolio pageSep 25
Averna Therapeutics Vaccines · United States Venture round $85M · 2 yr ago portfolio pageSep 25
Traws Pharma United States Venture round $14M · 2 yr ago portfolio pageSep 25
Enliven Therapeutics Drug Discovery · United States Venture round $90M · 2 yr ago portfolio pageSep 25
Mirador Therapeutics Drug Discovery · United States Venture round $333M · 2 yr ago 3 roles portfolio pageSep 25
Vanqua Bio Neurology & CNS Therapeutics · United States Venture round $45M · 2 yr ago portfolio pageSep 25
BioAge Labs Drug Discovery · United States Venture round $194.4M · 2 yr ago 2 roles portfolio pageSep 25
Forward Therapeutics Venture round $50M · 2 yr ago portfolio pageSep 25
Evozyne United States Series B $81M · 3 yr ago portfolio pageSep 25
Corteria Series A $70.7M · 3 yr ago lead portfolio page, round in the pressSep 6, 2023
Createrna Series A · 3 yr ago portfolio pageSep 25
mdxhealth Diagnostic Tests & IVD · Belgium Venture round $5M · 4 yr ago 1 role portfolio pageSep 25
DELFI Diagnostics Diagnostic Tests & IVD · United States Venture round $225M · 4 yr ago 6 roles portfolio pageSep 25
Alterome Oncology Therapeutics · United States Venture round $63.8M · 4 yr ago 1 role portfolio pageSep 25
GentiBio Cell & Gene Therapy · United States Series A $157M · 5 yr ago portfolio pageSep 25
Kumquat Biosciences Oncology Therapeutics · United States Venture round $30M · 5 yr ago 2 roles portfolio pageSep 25
Neurogastrx United States Venture round $60M · 5 yr ago portfolio pageSep 25
Pee Safe Personal Care · India Venture round $3M · 5 yr ago portfolio pageSep 25
Pathai Medical AI · United States Series C $165M · 5 yr ago 16 roles portfolio pageSep 25
Neurelis APIs & Drug Manufacturing · United States Venture round $114.8M · 5 yr ago 5 roles portfolio pageSep 25
Variantyx - Genomics & Genetic Testing · United States Venture round $15.6M · 5 yr ago portfolio pageSep 25
Propeller Venture round $864k · 5 yr ago portfolio pageSep 25
Noctrix Health Neurotech & Neuromodulation · United States Venture round $16.9M · 5 yr ago 20 roles portfolio pageSep 25
page United States Venture round $55k · 6 yr ago portfolio pageSep 25
Prelude Therapeutics Oncology Therapeutics · United States Venture round $50M · 6 yr ago 3 roles portfolio pageSep 25
Perfuse Therapeutics United States Venture round $9M · 6 yr ago portfolio pageSep 25
Compass Therapeutics Drug Discovery · United States Venture round $60.5M · 6 yr ago 2 roles portfolio pageSep 25
Shattuck Labs Immunology & Inflammation Therapeutics · United States Venture round $83M · 6 yr ago 1 role portfolio pageSep 25
Helicore Biopharma United States Venture round $2M · 6 yr ago portfolio pageSep 25
Avitide Venture round $10M · 7 yr ago portfolio pageSep 25
AirStrip® Medical AI · United States Venture round $21.5M · 7 yr ago 7 roles portfolio pageSep 25
Telabio Venture round $10.6M · 7 yr ago portfolio pageSep 25
acutusmedical.com Venture round $136.7M · 7 yr ago portfolio pageSep 25
memebox Brewing & Beer · United States Venture round $35M · 7 yr ago portfolio pageSep 25
Emergent BioSolutions Public Health & Prevention · United States Venture round $47.9M · 8 yr ago 15 roles portfolio pageSep 25
Sikka Software Corporation Autonomous Driving · United States Series C $10.5M · 11 yr ago portfolio pageSep 25
Starling Oncology Cancer Care Centers · United States 57 roles portfolio pageSep 25
Myriad Genetics Genomics & Genetic Testing · United States 20 roles portfolio pageSep 25
Disc Medicine Rare Disease Therapeutics · United States 17 roles portfolio pageSep 25
NeuroPace Neurotech & Neuromodulation · United States 16 roles portfolio pageSep 25
MBX Biosciences Cardiometabolic Therapeutics · United States 11 roles portfolio pageSep 25
Tiger Connect Patient Access & Booking · United States 11 roles portfolio pageSep 25
jx-care Senior Living & Assisted Living 10 roles portfolio pageSep 25
Velsera Precision Medicine · India 10 roles portfolio pageSep 25
MedPharm APIs & Drug Manufacturing · United States 9 roles portfolio pageSep 25
Carrot Fertility Health Insurance & Benefits · United States 8 roles portfolio pageSep 25
Janux Therapeutics | Novel T Cell Immunotherapies Oncology Therapeutics · United States 8 roles portfolio pageSep 25
Lexeo Therapeutics Rare Disease Therapeutics · United States 8 roles portfolio pageSep 25
ADARx Pharmaceuticals Drug Discovery · United States 6 roles portfolio pageSep 25
Intellia Therapeutics Cell & Gene Therapy · United States 5 roles portfolio pageSep 25
Magenta Med Cardiovascular Devices 5 roles portfolio pageSep 25
Kapiva Health & Wellness Products 6 roles portfolio pageSep 25
MDClone Synthetic Data · Israel 4 roles portfolio pageSep 25
Aura Biosciences Drug Discovery · United States 2 roles portfolio pageSep 25
Trisalus Life Sciences Drug Discovery · United States 2 roles portfolio pageSep 25
Verrica Pharmaceuticals Dermatology · United States 2 roles portfolio pageSep 25
Adicet Bio Oncology Therapeutics · United States 1 role portfolio pageSep 25
Angitia Biopharmaceuticals Biologics & Biosimilars · China 1 role portfolio pageSep 25
Crinetics Drug Discovery · United States 1 role portfolio pageSep 25
Radius Health, Inc. Prescription Drugs · United States 1 role portfolio pageSep 25
Adcendo Biologics & Biosimilars portfolio pageSep 25
ADELA Medical Laboratories portfolio pageSep 25
Advanced Enzymes Animal Nutrition · India portfolio pageSep 25
AirNexis Respiratory & Sleep Devices portfolio pageSep 25
12

Focus

Markets
Health Care78%
Biotechnology33%
Artificial Intelligence9%
Food & Beverages3%
Science & Engineering2%
Consumer Goods2%
Manufacturing2%
Consumer Electronics2%
Where its companies are
United States32%
China4%
India3%
Israel2%
Canada1%
United Kingdom1%
Belgium1%
Switzerland1%
Stage of its companies
Series A50%
Series C and later25%
Series B25%

Questions about OrbiMed

How many companies has OrbiMed invested in?

OrbiMed is known to hold 197 companies: 75 startups, and 57 exits so far, read from its own portfolio page and the funding rounds that name it.

Is OrbiMed investing now?

Yes: in the last 12 months 1 rounds in the press named OrbiMed (1 as the lead), and 0 companies joined its portfolio page in 90 days.

What does OrbiMed invest in?

The markets of the companies OrbiMed holds: Health Care (78%), Biotechnology (33%), Artificial Intelligence (9%), Food & Beverages (3%), Science & Engineering (2%).

Which OrbiMed portfolio companies are hiring?

48 companies OrbiMed holds are hiring now, with 364 open roles listed on this page.

Who does OrbiMed invest alongside?

The investors that hold the most companies together with OrbiMed: RA Capital Management, Foresite Capital, SR One, Wellington Management, NEA.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Nov 8; 4 rounds in the press that name it

OrbiMed portfolio: 197 known companies. Alion, Nov 17, 2026. https://alion.io/company/orbimed/portfolio

Licence: CC BY-SA 4.0JSON